Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities    
Net (loss) / income $ (16,084) $ (10,742)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,584 237
Amortization of debt discount 726 1,070
Interest accrued 36 335
PIK Interest 68 0
Finance Costs 1,350 0
Fair value of financing costs related to conversion options 1,479 0
Stock and stock option compensation 1,354 487
Issuance of common stock and warrants 406 0
Stock issued for services 2,173 3,150
Stock issued as settlement of debt with a supplier 24 542
Settlement of debt with a supplier 182 0
Revaluation of contingent liability (603) 44
Increase in fair value of derivative liabilities 811 21
Loss on disposal of leasehold improvements 8 0
(Increase) / decrease in assets, net of effect of disposal of subsidiary:    
Accounts receivable (1,506) (322)
Deposits 439 0
Prepaid expenses and other current assets 346 (34)
Increase / (decrease) in liabilities, net of effect of disposal of subsidiary:    
Accounts payable (443) (435)
Accrued license fees 3,011 (155)
Accrued compensation 229 (75)
Other liabilities and other items (2,501) 15
Net cash used in operating activities (6,911) (5,862)
Cash flows from investing activities    
Purchase of property and equipment (61) 0
Cash used in acquisition of subsidiary (1,287) (3,416)
Cash acquired with acquisition of subsidiary 513 59
Net cash used in investing activities (835) (3,357)
Cash flows from financing activities    
Repayment of debt obligations (3,657)  
Issuance of shares for cash 14,924 2,000
Net cash provided by financing activities 11,267 2,000
Effect of exchange rate changes on cash and cash equivalents (14) 61
Net change in cash and cash equivalents 3,507 (7,158)
Cash and cash equivalents, beginning of period 1,149 8,799
Cash and cash equivalents, end of period 4,656 1,641
Supplemental disclosure of cash flow information:    
Taxes paid 19 28
Noncash investing and financing activities:    
Contingency earn out on acquisition of subsidiary, net of discount 238 758
Common stock of the Company issued for pending acquisition of an asset   533
Common stock of the Company issued for acquisition of subsidiary 4,449 787
Exercise of warrants to purchase common stock of the Company $ 0 $ 473